申请人:Spark Biopharma, Inc.
公开号:US20210198260A1
公开(公告)日:2021-07-01
The present invention relates to a novel phosphor-tetrazine and a use thereof and, more particularly, provides a novel compound having high fluorescence amplification efficiency in various wavelength ranges by using a compound having a novel core skeleton called tert-butyl (3-(7-(6-methyl-1,2,4,5-tetrazin-3 -yl)-3-oxo-9-phenyl-1H-pyrrolo[3,4-b]indolizin-2(3H)-yl)propyl)carbamate.
本发明涉及一种新型磷光-四唑及其用途,更具体地提供了一种通过使用一种名为叔丁基(3-(7-(6-甲基-1,2,4,5-四唑-3-基)-3-氧代-9-苯基-1H-吡咯并[3,4-b]吲哚啉-2(3H)-基)丙基)氨基甲酸酯的新型核心骨架具有高荧光增强效率的新化合物。